{
    "root": "2fffe23d-37c8-34fe-e063-6294a90a7b6c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nortriptyline Hydrochloride",
    "value": "20250310",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "BUTYLPARABEN",
            "code": "3QPI1U3FV8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_88542"
        },
        {
            "name": "EDETATE CALCIUM DISODIUM",
            "code": "25IH6R4SGF",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14598"
        },
        {
            "name": "SODIUM PROPIONATE",
            "code": "DK6Y9P42IN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_132106"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "NORTRIPTYLINE HYDROCHLORIDE",
            "code": "00FN6IH15D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7641"
        }
    ],
    "indications": {
        "text": "nortriptyline hydrochloride , usp indicated relief symptoms depression . endogenous depressions likely alleviated depressive states .",
        "doid_entities": [
            {
                "text": "depression (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "nortriptyline hydrochloride recommended children . nortriptyline hydrochloride administered orally form capsules . lower usual dosages recommended elderly patients adolescents . lower dosages also recommended outpatients hospitalized patients close supervision . physician initiate low level increase gradually , noting carefully response evidence intolerance . following remission , maintenance medication may required longer period time lowest dose maintain remission . patient develops minor side effects , reduced . discontinued promptly effects serious nature allergic manifestations occur . usual adult dose - 25 mg three four times daily ; begin low level increased required . alternate regimen , total daily may given day . doses 100 mg daily administered , plasma levels nortriptyline monitored maintained optimum range 50 150 ng/ml . doses 150 mg/day recommended . elderly adolescent patients - 30 50 mg/day , divided doses , total daily may given day .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "nortriptyline hydrochloride capsules usp ( equivalent 10 mg nortriptyline ) # 3 , opaque deep green opaque white capsules imprinted nortriptylineand 10 mgsupplied bottles 100 ( ndc 75907-069-01 ) 500 ( ndc 75907-069-05 ) . nortriptyline hydrochloride capsules usp ( equivalent 25 mg nortriptyline ) # 1 , opaque deep green opaque white capsules imprinted nortriptylineand 25 mgsupplied bottles 100 ( ndc 75907-070-01 ) 500 ( ndc 75907-070-05 ) . nortriptyline hydrochloride capsules usp ( equivalent 50 mg nortriptyline ) # 1 , opaque white capsules imprinted nortriptylineand 50 mgsupplied bottles 100 ( ndc 75907-071-01 ) 500 ( ndc 75907-071-05 ) . nortriptyline hydrochloride capsules usp ( equivalent 75 mg nortriptyline ) # 1 , opaque deep green capsules imprinted nortriptylineand 75 mgsupplied bottles 100 ( ndc 75907-072-01 ) .",
    "adverseReactions": null,
    "indications_original": "Nortriptyline hydrochloride, USP is indicated for the relief of symptoms of depression. Endogenous depressions are more likely to be alleviated than are other depressive states.",
    "contraindications_original": "Nortriptyline hydrochloride is not recommended for children.\n                  Nortriptyline hydrochloride is administered orally in the form of capsules. Lower than usual dosages are recommended for elderly patients and adolescents. Lower dosages are also recommended for outpatients than for hospitalized patients who will be under close supervision. The physician should initiate dosage at a low level and increase it gradually, noting carefully the clinical response and any evidence of intolerance. Following remission, maintenance medication may be required for a longer period of time at the lowest dose that will maintain remission.\n                  If a patient develops minor side effects, the dosage should be reduced. The drug should be discontinued promptly if adverse effects of a serious nature or allergic manifestations occur.\n                  \n                     \n                        Usual Adult Dose\n                     - 25 mg three or four times daily; dosage should begin at a low level and be increased as required. As an alternate regimen, the total daily dosage may be given once a day. When doses above 100 mg daily are administered, plasma levels of nortriptyline should be monitored and maintained in the optimum range of 50 to 150 ng/mL. Doses above 150 mg/day are not recommended.\n\n \n                  \n                     \n                        Elderly and Adolescent Patients\n                     - 30 to 50 mg/day, in divided doses, or the total daily dosage may be given once a day.",
    "warningsAndPrecautions_original": "Nortriptyline Hydrochloride Capsules USP (equivalent to 10 mg nortriptyline) are #3, opaque deep green and opaque white capsules imprinted\n  \n   NORTRIPTYLINEand\n  \n   m 10 mgsupplied in bottles of 100 (NDC 75907-069-01) and 500 (NDC 75907-069-05).\n \n  \n                     Nortriptyline Hydrochloride Capsules USP (equivalent to 25 mg nortriptyline) are #1, opaque deep green and opaque white capsules imprinted\n  \n   NORTRIPTYLINEand\n  \n   m 25 mgsupplied in bottles of 100 (NDC 75907-070-01) and 500 (NDC 75907-070-05).\n \n  \n                     Nortriptyline Hydrochloride Capsules USP (equivalent to 50 mg nortriptyline) are #1, opaque white capsules imprinted\n  \n   NORTRIPTYLINEand m\n  \n   50 mgsupplied in bottles of 100 (NDC 75907-071-01) and 500 (NDC 75907-071-05).\n \n  \n                     Nortriptyline Hydrochloride Capsules USP (equivalent to 75 mg nortriptyline) are #1, opaque deep green capsules imprinted\n  \n   NORTRIPTYLINEand m\n  \n   75 mgsupplied in bottles of 100 (NDC 75907-072-01).",
    "drug": [
        {
            "name": "Nortriptyline Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7641"
        }
    ]
}